Undervalued based on future growth
Results
4
Companies which can be considered undervalued when accounting for expected future growth (PEG under 0.8)
4 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
SQURPHARMA | ৳222.50 | 2.3% | 9.2% | ৳197.2b | ৳352.20 | 7.6 | 11.4% | 5.4% | Pharmaceuticals & Biotech | ||
BXPHARMA | ৳145.30 | 15.0% | 77.6% | ৳64.8b | ৳153.00 | 10.2 | 14.4% | 2.8% | Pharmaceuticals & Biotech | ||
RENATA | ৳453.20 | 2.5% | -5.8% | ৳52.0b | ৳615.05 | 19.0 | 30.0% | 1.2% | Pharmaceuticals & Biotech | ||
BSCPLC | ৳148.80 | 0.7% | 26.5% | ৳27.8b | ৳162.80 | 9.8 | 27.1% | 2.7% | Telecom |
Page 1 of 1